Health Services Utilization and Payments in Patients With Cancer Pain: A Comparison of Intrathecal Drug Delivery vs. Conventional Medical Management. Issue 2 (27th January 2016)

• Record Type: Journal Article
• Authors: Stearns, Lisa J.; Hinnenthal, Jennifer A.; Hammond, Krisstin; Berryman, Eric; Janjan, Nora A.
• Is Part Of: Neuromodulaton. Volume 19:Issue 2(2016)
• Page Start: 196
• Page End: 205
• Publication Date: 2016-01-27
• Subjects: Cancer pain -- conventional medical management -- health services utilization -- intrathecal drug delivery -- retrospective study; Central nervous system -- Physiology -- Periodicals; Central nervous system -- Diseases -- Periodicals; 616.8
• DOI: 10.1111/ner.12384
• Languages: English
• ISSNs: 1094-7159

Abstract

Abstract : Introduction: To compare health services utilization and payments for cancer patients who received an implantable intrathecal drug delivery (IDD) system, consisting of a pump and catheter, vs. conventional medical management (CMM) for the treatment of cancer‐related pain. Methods: This retrospective claims‐data analysis compared health services utilization and payments in a population of patients receiving either IDD or CMM for treatment of cancer pain. Patients were propensity score‐matched 1:1 based on characteristics including, but not limited to, age, gender, cancer type, comorbid conditions, and health care utilization and payments. Results: From a sample of 142 IDD patients and 3188 CMM patients who met all inclusion/exclusion criteria, 73 matched pairs were obtained. In the year following implant, IDD patients had a consistent trend of lower medical utilization, and total payments that were $3195 lower compared to CMM. Conclusions: Despite the high initial cost of IDD, this analysis suggests that patients with IDD incur lower medical utilization and payments over the first year post‐implant. Further analysis comprised of a larger, longitudinal sample would contribute to health economics and outcomes research, and assist with future practice guideline development.